NICM
MDCO

Neo Ivy Capital Management’s Medicines Co MDCO Stock Holding History

Neo Ivy Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-23,536
Closed -$988K – 432
2019
Q3 		$988K Buy
23,536
+18,948
+413% +$756K 0.65% 53
2019
Q2 		$167K Buy
+4,588
New +$150K 0.09% 214

Other funds holding MDCO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Neo Ivy Capital Management's MDCO Position: Q4 2019 in Review

Neo Ivy Capital Management sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 23,536 shares — an estimated $988K sold.

Neo Ivy Capital Management first reported a position in MDCO in Q2 2019 and held it in 2 quarters. The position peaked at $988K in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Neo Ivy Capital Management reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Neo Ivy Capital Management sold 23,536 Medicines Co shares in Q4 2019, an estimated $988K.
  • Neo Ivy Capital Management first reported a position in Medicines Co in Q2 2019 and held it in 2 quarters.
  • Neo Ivy Capital Management's Medicines Co position peaked at $988K in Q3 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Neo Ivy Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.